Financials
- Market Capitalization 443.17 M
- Employee 88
- Founded 1994
- CEO Craig A Tooman
- Website www.silence-therapeutics.com
- Headquarter United Kingdom
- FIGI BBG00WVTHPN2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-9.65
Relación precio/flujo de caja
1 541.15
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2906 | AUTL Autolus Therapeutics plc - American Depositary Shares | 1.70 USD | -2.30% | -7.10% | -8.60% | +6.92% | 452.48 M USD | ||
| 2914 | ENTX Entera Bio Ltd. - Ordinary Shares | 2.61 USD | -1.51% | +0.38% | -7.12% | +2.35% | 451.90 M USD | ||
| 2929 | YDES YD Bio Limited - Ordinary Shares | 6.33 USD | 0.00% | +1.93% | +57.86% | -65.60% | 448.10 M USD | ||
| 2939 | DMAC DiaMedica Therapeutics Inc. - Common Stock | 8.15 USD | -0.61% | -4.57% | +25.58% | +15.77% | 439.49 M USD |